The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rabies Vaccine Market Research Report 2024
Synopsis
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
The global Rabies Vaccine market was valued at US$ 931 million in 2023 and is anticipated to reach US$ 1229.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.
Report Scope
The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
The global Rabies Vaccine market was valued at US$ 931 million in 2023 and is anticipated to reach US$ 1229.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.
Report Scope
The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Rabies Vaccine
1.2 Rabies Vaccine Segment by Type
1.2.1 Global Rabies Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Rabies Vaccine Segment by Application
1.3.1 Global Rabies Vaccine Market Value by Application: (2024-2030)
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Global Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Rabies Vaccine Revenue 2019-2030
1.4.2 Global Rabies Vaccine Sales 2019-2030
1.4.3 Global Rabies Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rabies Vaccine Market Competition by Manufacturers
2.1 Global Rabies Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rabies Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Rabies Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Vaccine, Product Type & Application
2.7 Rabies Vaccine Market Competitive Situation and Trends
2.7.1 Rabies Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Vaccine Players Market Share by Revenue
2.7.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Rabies Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rabies Vaccine Global Rabies Vaccine Sales by Region: 2019-2030
3.2.1 Global Rabies Vaccine Sales by Region: 2019-2024
3.2.2 Global Rabies Vaccine Sales by Region: 2025-2030
3.3 Global Rabies Vaccine Global Rabies Vaccine Revenue by Region: 2019-2030
3.3.1 Global Rabies Vaccine Revenue by Region: 2019-2024
3.3.2 Global Rabies Vaccine Revenue by Region: 2025-2030
3.4 North America Rabies Vaccine Market Facts & Figures by Country
3.4.1 North America Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rabies Vaccine Sales by Country (2019-2030)
3.4.3 North America Rabies Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rabies Vaccine Sales by Country (2019-2030)
3.5.3 Europe Rabies Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rabies Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Rabies Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rabies Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Rabies Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rabies Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rabies Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Vaccine Sales by Type (2019-2030)
4.1.1 Global Rabies Vaccine Sales by Type (2019-2024)
4.1.2 Global Rabies Vaccine Sales by Type (2025-2030)
4.1.3 Global Rabies Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Rabies Vaccine Revenue by Type (2019-2030)
4.2.1 Global Rabies Vaccine Revenue by Type (2019-2024)
4.2.2 Global Rabies Vaccine Revenue by Type (2025-2030)
4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Rabies Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rabies Vaccine Sales by Application (2019-2030)
5.1.1 Global Rabies Vaccine Sales by Application (2019-2024)
5.1.2 Global Rabies Vaccine Sales by Application (2025-2030)
5.1.3 Global Rabies Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Rabies Vaccine Revenue by Application (2019-2030)
5.2.1 Global Rabies Vaccine Revenue by Application (2019-2024)
5.2.2 Global Rabies Vaccine Revenue by Application (2025-2030)
5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Rabies Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK (Novartis)
6.1.1 GSK (Novartis) Corporation Information
6.1.2 GSK (Novartis) Description and Business Overview
6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
6.1.5 GSK (Novartis) Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Chengda
6.3.1 Chengda Corporation Information
6.3.2 Chengda Description and Business Overview
6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengda Rabies Vaccine Product Portfolio
6.3.5 Chengda Recent Developments/Updates
6.4 Yisheng
6.4.1 Yisheng Corporation Information
6.4.2 Yisheng Description and Business Overview
6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yisheng Rabies Vaccine Product Portfolio
6.4.5 Yisheng Recent Developments/Updates
6.5 Prcmise
6.5.1 Prcmise Corporation Information
6.5.2 Prcmise Description and Business Overview
6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Prcmise Rabies Vaccine Product Portfolio
6.5.5 Prcmise Recent Developments/Updates
6.6 VACN
6.6.1 VACN Corporation Information
6.6.2 VACN Description and Business Overview
6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 VACN Rabies Vaccine Product Portfolio
6.6.5 VACN Recent Developments/Updates
6.7 Changsheng
6.6.1 Changsheng Corporation Information
6.6.2 Changsheng Description and Business Overview
6.6.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changsheng Rabies Vaccine Product Portfolio
6.7.5 Changsheng Recent Developments/Updates
6.8 BCHT
6.8.1 BCHT Corporation Information
6.8.2 BCHT Description and Business Overview
6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BCHT Rabies Vaccine Product Portfolio
6.8.5 BCHT Recent Developments/Updates
6.9 Hissen
6.9.1 Hissen Corporation Information
6.9.2 Hissen Description and Business Overview
6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hissen Rabies Vaccine Product Portfolio
6.9.5 Hissen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Vaccine Industry Chain Analysis
7.2 Rabies Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Vaccine Production Mode & Process
7.4 Rabies Vaccine Sales and Marketing
7.4.1 Rabies Vaccine Sales Channels
7.4.2 Rabies Vaccine Distributors
7.5 Rabies Vaccine Customers
8 Rabies Vaccine Market Dynamics
8.1 Rabies Vaccine Industry Trends
8.2 Rabies Vaccine Market Drivers
8.3 Rabies Vaccine Market Challenges
8.4 Rabies Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
